Girentuximab
Girentuximab Basic information
- Product Name:
- Girentuximab
- Synonyms:
-
- Girentuximab
- Research Grade Girentuximab(DHH37201)
- Girentuximab (anti-CA9)
- cG250|||WX-G250|||G250
- Research Grade Girentuximab
- CAS:
- 916138-87-9
- MW:
- 0
- Mol File:
- Mol File
More
Less
Girentuximab Chemical Properties
- storage temp.
- Store at -20°C
- form
- Liquid
- color
- Colorless to light yellow
More
Less
Girentuximab Usage And Synthesis
Uses
Girentuximab (G250) is a chimeric monoclonal antibody that binds carbonic anhydrase IX (CAIX), a cell surface glycoprotein ubiquitously expressed in clear cell renal cell carcinoma (ccRCC)[1].
IC 50
CA Ⅸ
References
[1] Chamie K, et al. Adjuvant Weekly Girentuximab Following Nephrectomy for High-Risk Renal Cell Carcinoma: The ARISER Randomized Clinical Trial. JAMA Oncol. 2017;3(7):913-920. DOI:10.1001/jamaoncol.2016.4419
GirentuximabSupplier
Shanghai YuanYe Biotechnology Co., Ltd.
- Tel
- 021-61312847; 18021002903
- 3008007409@qq.com
ShangHai Biochempartner Co.,Ltd
- Tel
- 177-54423994 17754423994
- 2853530910@QQ.com
Wuhan Chemstan Biotechnology Co., Ltd.
- Tel
- 027-65317797 15926423062
- 422450190@qq.com
TargetMol Chemicals Inc.
- Tel
- 4008200310
- marketing@tsbiochem.com
Biolab Reagents
- Tel
- 027-65279366 18108604356
- products@biolabreagent.com